JP2013515019A5 - - Google Patents

Download PDF

Info

Publication number
JP2013515019A5
JP2013515019A5 JP2012545091A JP2012545091A JP2013515019A5 JP 2013515019 A5 JP2013515019 A5 JP 2013515019A5 JP 2012545091 A JP2012545091 A JP 2012545091A JP 2012545091 A JP2012545091 A JP 2012545091A JP 2013515019 A5 JP2013515019 A5 JP 2013515019A5
Authority
JP
Japan
Prior art keywords
poloxamer
polysorbate
suspension
surfactant
particle size
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012545091A
Other languages
English (en)
Japanese (ja)
Other versions
JP5816194B2 (ja
JP2013515019A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2010/000183 external-priority patent/WO2011076208A2/en
Publication of JP2013515019A publication Critical patent/JP2013515019A/ja
Publication of JP2013515019A5 publication Critical patent/JP2013515019A5/ja
Application granted granted Critical
Publication of JP5816194B2 publication Critical patent/JP5816194B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012545091A 2009-12-22 2010-12-22 カルシポトリオール一水和物ナノクリスタル Expired - Fee Related JP5816194B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPCT/DK2009/000267 2009-12-22
DK2009000267 2009-12-22
US29309110P 2010-01-07 2010-01-07
US61/293,091 2010-01-07
PCT/DK2010/000183 WO2011076208A2 (en) 2009-12-22 2010-12-22 Calcipotriol monohydrate nanocrystals

Publications (3)

Publication Number Publication Date
JP2013515019A JP2013515019A (ja) 2013-05-02
JP2013515019A5 true JP2013515019A5 (cg-RX-API-DMAC7.html) 2013-12-26
JP5816194B2 JP5816194B2 (ja) 2015-11-18

Family

ID=43618145

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012545091A Expired - Fee Related JP5816194B2 (ja) 2009-12-22 2010-12-22 カルシポトリオール一水和物ナノクリスタル

Country Status (15)

Country Link
US (2) US20130039952A1 (cg-RX-API-DMAC7.html)
EP (1) EP2515874B1 (cg-RX-API-DMAC7.html)
JP (1) JP5816194B2 (cg-RX-API-DMAC7.html)
CN (1) CN102770125B (cg-RX-API-DMAC7.html)
AU (1) AU2010335655B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012015449B1 (cg-RX-API-DMAC7.html)
CA (1) CA2785253A1 (cg-RX-API-DMAC7.html)
ES (1) ES2523119T3 (cg-RX-API-DMAC7.html)
IL (1) IL220516A (cg-RX-API-DMAC7.html)
MX (1) MX2012007234A (cg-RX-API-DMAC7.html)
NZ (1) NZ601000A (cg-RX-API-DMAC7.html)
PL (1) PL2515874T3 (cg-RX-API-DMAC7.html)
RU (1) RU2555339C2 (cg-RX-API-DMAC7.html)
WO (1) WO2011076208A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201204618B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR122019026637B1 (pt) * 2013-07-18 2023-09-26 Mannkind Corporation Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco
CN105534996B (zh) * 2016-02-24 2018-05-01 长沙佰顺生物科技有限公司 一种治疗银屑病的药物组合物
KR20190042558A (ko) 2016-07-05 2019-04-24 크라토스 엘엘씨 부동태화된 예비리튬화된 마이크론 및 서브마이크론 iva족 입자 및 이의 제조방법
US11637280B2 (en) 2017-03-31 2023-04-25 Kratos LLC Precharged negative electrode material for secondary battery
CN108904445A (zh) * 2018-08-06 2018-11-30 江苏知原药业有限公司 钙泊三醇纳米悬浮液
CN109157661B (zh) * 2018-09-10 2021-09-24 南京工业大学 一种配体辅助下用氧化物silica包覆疏水性分子晶体的方法
RU2749360C1 (ru) * 2020-10-09 2021-06-09 Федеральное государственное бюджетное военное образовательное учреждение высшего образования "Военно-медицинская академия имени С.М. Кирова" Министерства обороны Российской Федерации (ВМедА) Способ лечения ладонно-подошвенного пустулеза
JP7751298B2 (ja) * 2021-07-14 2025-10-08 株式会社ツツミプランニング 浸透深さの調整方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8315787D0 (en) * 1983-06-08 1983-07-13 Briggs J H Coolant spray
US4758432A (en) * 1984-10-15 1988-07-19 Richardson-Vicks Inc. Topical treatment of skin inflammatory disorders
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
USRE39706E1 (en) * 1993-01-15 2007-06-26 Leo Pharma A/S Crystalline form of a vitamin D analogue
DE4440337A1 (de) * 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
GB9504265D0 (en) * 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
DE19932157A1 (de) 1999-07-13 2001-01-18 Pharmasol Gmbh Verfahren zur schonenden Herstellung von hochfeinen Mikropartikeln und Nanopartikeln
US6403654B1 (en) * 2000-04-13 2002-06-11 Mariana De Oliveira Compositions for and method of treatment for psoriasis
WO2002034235A1 (en) * 2000-10-27 2002-05-02 Leo Pharma A/S Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
WO2002045691A2 (en) * 2000-12-06 2002-06-13 Pharmacia Corporation Laboratory scale milling process
FR2834212B1 (fr) * 2001-12-27 2004-07-09 Besins Int Belgique Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques
AU2002356294A1 (en) 2002-12-13 2004-07-09 Jagotec Ag A topical nanoparticulate spironolactone formulation
RU2396250C2 (ru) 2003-07-24 2010-08-10 Лео Фарма А/С Новые производные аминобензофенона
JP2007536259A (ja) * 2004-05-06 2007-12-13 イヴレア ファーマスーティカルズ インコーポレイテッド 活性薬剤の送達のための粒子
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
EP1828148B1 (en) 2004-12-13 2010-01-20 Leo Pharma A/S Triazole substituted aminobenzophenone compounds
ES2447301T3 (es) * 2005-06-01 2014-03-11 Glaxosmithkline Intellectual Property Development Limited Formulación vitamínica
US20070154402A1 (en) * 2005-10-24 2007-07-05 Collegium Pharmaceutical, Inc. Topical Pharmaceutical Foam Composition
JP5508003B2 (ja) * 2006-06-30 2014-05-28 アイスイティカ ピーティーワイ リミテッド ナノ粒子状の形態における生物学的に活性な化合物の調製のための方法
WO2008058755A1 (en) * 2006-11-17 2008-05-22 Abbott Gmbh & Co. Kg Nanocrystals for use in topical cosmetic formulations and method of production thereof
US8148537B2 (en) 2006-12-22 2012-04-03 Leo Pharma A/S Substituted acetophenones useful as PDE4 inhibitors
PL2114951T3 (pl) 2007-02-28 2014-10-31 Leo Pharma As Nowe inhibitory fosfodiesterazy
CN101677979A (zh) 2007-04-19 2010-03-24 利奥制药有限公司 Src家族激酶抑制剂
JP2010526824A (ja) 2007-05-11 2010-08-05 ソネボーン インコーポレイテッド シリコーン類似の特性を有するワセリン
PL2379548T3 (pl) 2008-12-19 2016-08-31 Leo Pharma As Triazolopirydyny jako inhibitory fosfodiesterazy do leczenia chorób skórnych

Similar Documents

Publication Publication Date Title
CN109963555A (zh) 一种包含美洛昔康的可注射的药物组合物及其制备方法
EP3495446A3 (en) Particles containing one or more controlled release cross-linked active agents
Jakubowska et al. Freeze-drying of drug nanosuspension–study of formulation and processing factors for the optimization and characterization of redispersible cilostazol nanocrystals
MX2023004255A (es) Comprimidos que comprenden 2-hidroxi-6-((2-(1-isopropil-1h-pirazol -5-il)piridin-3-il)metoxi)benzaldehido.
WO2012051426A3 (en) Aggregate nanoparticulate medicament formulations, manufacture and use thereof
NZ728721A (en) Pharmaceutical nanoparticles showing improved mucosal transport
WO2007107571A3 (en) Casting process
AR110269A1 (es) Preparación de nanopartículas de ciclodextrina para la administración de fármacos oftálmicos
AR067747A1 (es) Metodos para producir suspension de aripiprazol y formulacion liofilizada
AR093764A1 (es) Composiciones de limpieza que comprenden particulas estructuradas
RU2017108432A (ru) Жидкая ингаляционная композиция, содержащая rpl 554
JP2010514660A5 (cg-RX-API-DMAC7.html)
WO2011063990A8 (en) Spider silk particles for controlled and sustained delivery of compounds
WO2011106075A3 (en) A microelectronic structure including a low k dielectric and a method of controlling carbon distribution in the structure
MX2018011190A (es) Cuerpo de dispersion de particulas finas de material de proteccion de infrarrojo cercano, cuerpo de proteccion de infrarrojo cercano y estructura laminada de proteccion de infrarrojo cercano y metodo de produccion de los mismos.
CN102488920B (zh) 核壳结构的α-半水硫酸钙/羟基磷灰石复合颗粒及制备
AR078348A1 (es) Proceso para producir granulos
WO2013132457A3 (en) Nanocrystalline solid dispersion compositions and process of preparation thereof
WO2017177004A8 (en) Tertiary amides and method of use
NZ601000A (en) Calcipotriol monohydrate nanocrystals
WO2010102923A3 (en) Riluzole aqueous suspensions
HK1214951A1 (zh) 眼用製劑
RU2016112178A (ru) Способ получения композиции для личной гигиены с использованием уплотненных модификаторов реологии
WO2013025442A3 (en) Concentrated felbamate formulations for parenteral administration
MY169360A (en) Stable nanoparticulate suspension and method for production